|
Hyperpolarized Bicarbonate (13C) Clinical Trials
1 actively recruiting trial across 1 location
Also known as: HP C13, Hyperpolarized (HP) bicarbonate 13 (13C)
Pipeline
Early 1: 1
Top Sponsors
- Robert Flavell, MD, PhD1
Indications
- Localized Prostate Carcinoma1
- Prostate Cancer1
- Cancer1
San Francisco, California1 trial
Magnetic Resonance (MR) Imaging With Hyperpolarized Bicarbonate (13C) to Measure Tissue pH in Prostate Cancer
University of California, San Francisco
Early 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.